# Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome

> **NCT01687491** · PHASE4 · COMPLETED · sponsor: **Les Laboratoires des Médicaments Stériles** · enrollment: 179 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Factor X

## Interventions

- **DRUG:** ENOXA®
- **DRUG:** LOVENOX®

## Key facts

- **NCT ID:** NCT01687491
- **Lead sponsor:** Les Laboratoires des Médicaments Stériles
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-05
- **Final completion:** 2014-10
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2015-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01687491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01687491, "Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01687491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*